Esther Rajavelu Initiated (TXMD) at Strong Buy and Held Target at $10 on, Jul 21st, 2017
Esther has made no other calls on TXMD in the last 4 months.
There is 1 other peer that has a rating on TXMD. Out of the 1 peers that are also analyzing TXMD, 0 agree with Esther's Rating of Hold.
This is the rating of the analyst that currently disagrees with Esther
- Jay Olson of "Oppenheimer" Upgraded from Hold to Buy on, Tuesday, July 11th, 2017
on: Thu, Jul 13th 2017
by: WOPRAI
Tim Evans Initiated (BIO) at Buy and Held Target at $250 on, Jul 13th, 2017
on: Tue, Jul 11th 2017
by: WOPRAI
Eun Yang Initiated (BIIB) at Hold and Held Target at $310 on, Jul 11th, 2017
on: Thu, Jan 05th 2017
by: WOPRAI
on: Tue, Dec 06th 2016
by: WOPRAI
Annabel Samimy Maintained (TXMD) at Strong Buy with Increased Target to $17 on, Dec 6th, 2016
on: Fri, Nov 11th 2016
by: WOPRAI
on: Mon, Jul 11th 2016
by: WOPRAI
Ashish Sabadra Maintained (SSNC) at Hold with Decreased Target to $32 on, Jul 11th, 2016
on: Wed, Jul 01st 2015
by: WOPRAI
Sheryl Skolnick Initiated (AMED) at Strong Buy and Held Target at $45 on, Jul 1st, 2015
on: Wed, Nov 05th 2014
by: WOPRAI
Nishu Sood Initiated (TPH) at Strong Buy and Held Target at $18 on, Nov 5th, 2014
on: Fri, Jun 27th 2014
by: WOPRAI
Tore Svanberg Initiated (ADI) at Strong Buy and Held Target at $66 on, Jun 27th, 2014
on: Tue, Oct 15th 2013
by: WOPRAI
Michael Derchin Upgraded (ALK) to Buy and Increased Target to $35 on, Oct 15th, 2013
on: Mon, Jul 22nd 2013
by: WOPRAI
on: Tue, Mar 12th 2013
by: WOPRAI
Kate McShane Initiated (BBY) at Strong Buy and Held Target at $25 on, Mar 12th, 2013